Skip to main content

Testing of an Ultrasound-Limited Imaging Protocol for Pavlik harness Supervision (TULIPPS) in developmental dysplasia of the hip: a randomized controlled trial.

Publication ,  Journal Article
Behman, AL; Bradley, CS; Maddock, CL; Sharma, S; Kelley, SP
Published in: Bone Joint J
September 2022

AIMS: There is no consensus regarding optimum timing and frequency of ultrasound (US) for monitoring response to Pavlik harness (PH) treatment in developmental dysplasia of the hip (DDH). The purpose of our study was to determine if a limited-frequency hip US assessment had an adverse effect on treatment outcomes compared to traditional comprehensive US monitoring. METHODS: This study was a single-centre noninferiority randomized controlled trial. Infants aged under six months whose hips were reduced and centred in the harness at initiation of treatment (stable dysplastic or subluxable), or initially decentred (subluxated or dislocated) but reduced and centred within four weeks of PH treatment, were randomized to our current standard US monitoring protocol (every clinic visit) or to a limited-frequency US protocol (US only at end of treatment). Groups were compared based on α angle and femoral head coverage at the end of PH treatment, acetabular indices, and International Hip Dysplasia Institute (IHDI) grade on one-year follow-up radiographs. RESULTS: Overall, 100 patients were included; 42 patients completed the standard protocol (SP) and 40 completed the limited protocol (LP). There was no significant difference in mean right α angle at the end of treatment (SP 70.0° (SD 3.2°) ; LP 68.7° (SD 2.9°); p = 0.033), nor on the left (SP 69.0° (SD 3.5°); LP 68.1° (SD 3.3°); p = 0.128). There was no significant difference in mean right acetabular index at follow-up (SP 23.1° (SD 4.3°); LP 22.0° (SD 4.1°); p = 0.129), nor on the left (SP 23.3° (SD 4.2°); LP 22.8° (SD 3.9°); p = 0.284). All hips had femoral head coverage of > 50% at end of treatment, and all were IHDI grade 1 at follow-up. In addition, the LP group underwent a 60% reduction in US use once stable. CONCLUSION: Our study supports reducing the frequency of US assessment during PH treatment of DDH once a hip is reduced and centred.Cite this article: Bone Joint J 2022;104-B(9):1081-1088.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Bone Joint J

DOI

EISSN

2049-4408

Publication Date

September 2022

Volume

104-B

Issue

9

Start / End Page

1081 / 1088

Location

England

Related Subject Headings

  • Treatment Outcome
  • Infant
  • Humans
  • Developmental Dysplasia of the Hip
  • Acetabulum
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Behman, A. L., Bradley, C. S., Maddock, C. L., Sharma, S., & Kelley, S. P. (2022). Testing of an Ultrasound-Limited Imaging Protocol for Pavlik harness Supervision (TULIPPS) in developmental dysplasia of the hip: a randomized controlled trial. Bone Joint J, 104-B(9), 1081–1088. https://doi.org/10.1302/0301-620X.104B9.BJJ-2022-0350.R2
Behman, Amy L., Catharine S. Bradley, Connor L. Maddock, Smriti Sharma, and Simon P. Kelley. “Testing of an Ultrasound-Limited Imaging Protocol for Pavlik harness Supervision (TULIPPS) in developmental dysplasia of the hip: a randomized controlled trial.Bone Joint J 104-B, no. 9 (September 2022): 1081–88. https://doi.org/10.1302/0301-620X.104B9.BJJ-2022-0350.R2.
Behman, Amy L., et al. “Testing of an Ultrasound-Limited Imaging Protocol for Pavlik harness Supervision (TULIPPS) in developmental dysplasia of the hip: a randomized controlled trial.Bone Joint J, vol. 104-B, no. 9, Sept. 2022, pp. 1081–88. Pubmed, doi:10.1302/0301-620X.104B9.BJJ-2022-0350.R2.

Published In

Bone Joint J

DOI

EISSN

2049-4408

Publication Date

September 2022

Volume

104-B

Issue

9

Start / End Page

1081 / 1088

Location

England

Related Subject Headings

  • Treatment Outcome
  • Infant
  • Humans
  • Developmental Dysplasia of the Hip
  • Acetabulum